LIVANOVA PLC

LIVN is the ticker symbol for LivaNova PLC, a publicly traded medical technology company. The stock represents ownership in a business that develops and markets medical devices and therapies for cardiac surgery, neuromodulation, and other clinical areas. LIVN shares are listed on the Nasdaq Global Select Market. Investors track the stock as a way to participate in the medical device sector, and its price reflects the market's assessment of the company's operations, financial results, and future prospects.

LIVN operates in the medical technology, or medtech, industry. The company focuses on devices and therapies used in cardiac surgery, neuromodulation, and related areas of patient care. This sector is characterized by regulatory oversight, research and development spending, and reliance on clinical adoption. Industry conditions such as hospital capital spending, reimbursement policies, and competitive product launches can influence LIVN's business performance and how investors view the stock.

Recent performance for LIVN depends on current market trading and cannot be stated without up-to-date data. The stock's recent moves are typically shown in the price chart and performance statistics on this page, including changes over various periods. For the latest LIVN price, daily change, and recent return figures, refer to the live data displayed on the page. Performance can be affected by earnings reports, guidance updates, and broader market conditions.

Evaluating LIVN's valuation involves comparing its market price with fundamental measures such as earnings, sales, and cash flow. Common tools include the price-to-earnings ratio, price-to-sales ratio, and enterprise value multiples. It is also useful to compare these metrics with peers in the medical device industry and with LIVN's own historical ranges. Because valuation depends on current prices and financial results, investors should use the latest data available on this page.

To buy LIVN stock, you generally need a brokerage account that offers access to U.S. equity markets. Once the account is funded, you can place a buy order for LIVN shares through the broker's trading platform, choosing an order type such as market or limit. Fractional shares may be available depending on the broker. Before trading, review the current LIVN quote, any applicable fees, and your order details to ensure the trade meets your objectives.

LIVN faces risks common to medical device companies, including regulatory approvals, product safety or efficacy concerns, clinical trial outcomes, and competition from other devices or therapies. Changes in healthcare reimbursement, hospital spending, or global economic conditions can also affect demand. Additionally, currency fluctuations and supply chain disruptions may impact results. Investors should review LIVN's risk disclosures in its annual report and other SEC filings for a fuller picture of company-specific risks.